GlassScriptPhysician profile
Lynval Williams
NPI 1194210807
$4,038.29
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,025 · 2022: $1,461 · 2023: $1,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514 · Travel and Lodging: $38.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.98 |
| Travel and Lodging | $38.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $566.02 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $438.97 | 2021-2023 | Relistor |
| Collegium Pharmaceutical, INC. | $367.91 | 2021-2023 | Xtampza |
| Biohaven Pharmaceutical Holding Company LTD. | $326.49 | 2022 | |
| Abbott Laboratories | $326.30 | 2021-2023 | Proclaim |
| Lilly USA, LLC | $291.38 | 2021-2022 | |
| Curonix LLC | $249.57 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceuticals, INC. | $209.20 | 2021 | |
| Amgen INC. | $203.40 | 2021-2022 | |
| Nevro Corp. | $189.34 | 2021-2023 | Senza |
| Scilex Pharmaceuticals INC. | $158.18 | 2021-2023 | Ztlido |
| Medtronic, INC. | $151.90 | 2021-2023 | Intellis Adaptivestim, Synchromedii |
| Azurity Pharmaceuticals, INC. | $75.10 | 2023 | Horizant |
| Arbor Pharmaceuticals, INC. | $70.60 | 2021-2022 | |
| Pfizer INC. | $66.69 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $59.27 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Ibsa Pharma INC. | $49.18 | 2023 | Tirosint, Licart |
| Nalu Medical, INC. | $42.79 | 2021-2023 | Nalu Neurostimulation System |
| Allergan, INC. | $42.51 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $34.48 | 2021 | |
| Upsher-Smith Laboratories LLC | $24.89 | 2022 | |
| Almatica Pharma LLC | $21.23 | 2022 | |
| Redhill Biopharma INC. | $20.61 | 2022 | |
| Bioventus LLC | $14.21 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.74 | 2023 | Seglentis |
| Stimwave Technologies Incorporated | $12.63 | 2021 | |
| Biodelivery Sciences International, INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynval Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.